October 24, 2025 · Form 4 insider transaction
Grossman Adam S sold 15,000 shares of ADMA Biologics, Inc. at $16.00 per share, a transaction worth $240.0K. The trade was recorded as open-market sale under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 0 days after the transaction.
Transaction was effected pursuant to a Rule 10b5-1 trading plan entered into between the reporting person and Fidelity Brokerage Services LLC on December 5, 2024, as previously disclosed by the issuer.; The price reported in Column 4 is the price at which the shares were sold.